| Wed, Nov 11, 2009 | | • | HALOZYME THERAPEUTICS INC Financials
EDGAR Online Financials (Wed, Nov 11)
| | Tue, Nov 10, 2009 | | • | New Star Analyst Rankings for Halozyme Therapeutics, Inc.
StarMine (Tue, Nov 10)
| | Fri, Nov 6, 2009 | | • | Halozyme Study Results Demonstrate Significantly Less Absorption Variability for Insulin Lispro Administered with PH20 Enzyme
Business Wire (Fri, Nov 6)
| | • | Halozyme Therapeutics, Inc. Q3 2009 Earnings Call Transcript
at Seeking Alpha (Fri, Nov 6)
| | • | Halozyme takes bigger loss on testing expenses
AP (Fri, Nov 6)
| | • | Halozyme Earnings Call scheduled for 11:00 am ET today
CCBN (Fri, Nov 6)
| | • | HALOZYME THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and
EDGAR Online (Fri, Nov 6)
| | • | Halozyme Therapeutics Reports Third Quarter 2009 Financial Results
Business Wire (Fri, Nov 6)
| | • | Q3 2009 Halozyme Earnings Release - Before Market Open
CCBN (Fri, Nov 6)
| | • | HALOZYME THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 6)
| | Wed, Oct 28, 2009 | | • | Halozyme to Host Third Quarter Conference Call on November 6 and Present at Two Upcoming Investor Conferences
Business Wire (Wed, Oct 28)
| | Thu, Oct 22, 2009 | | • | Halozyme Announces Roche Doses First Patient in Phase 3 Clinical Trial with Subcutaneous Herceptin®
Business Wire (Thu, Oct 22)
| | Wed, Oct 21, 2009 | | • | Halozyme Study Results Show Faster Insulin Absorption when Administered in Combination with a Wide Range of PH20 Enzyme Concentrations
Business Wire (Wed, Oct 21)
| | Tue, Oct 20, 2009 | | • | Biotech Mergers And Acquisitions Will Accelerate According To Wedbush Morgan Expert Analyst As More Expensive Phase III Trials Force Small Biotech Companies Into Large Pharma Distribution And Finance Organizations
Wall Street Transcript (Tue, Oct 20)
| | Mon, Oct 19, 2009 | | • | Halozyme to Present at the BIOCOM Investor Conference on October 26
PR Newswire (Mon, Oct 19)
| | Tue, Oct 13, 2009 | | • | Halozyme Therapeutics upgraded by Wedbush Morgan
Briefing.com (Tue, Oct 13)
| | Thu, Oct 8, 2009 | | • | Halozyme Therapeutics to Host Analyst Meeting in New York on October 15
Business Wire (Thu, Oct 8)
| | Mon, Oct 5, 2009 | | • | Baxter Announces the Commercial Launch of HYLENEX at ACEP for Use in Pediatric Rehydration
Business Wire (Mon, Oct 5)
| | Fri, Oct 2, 2009 | | • | HALOZYME THERAPEUTICS INC Files SEC form 8-K, Unregistered Sale of Equity Securities
EDGAR Online (Fri, Oct 2)
| | Fri, Aug 7, 2009 | | • | Halozyme Earnings Call scheduled for 11:00 am ET today
CCBN (Fri, Aug 7)
|
Add HALO News to My Yahoo!:
 
| |
|
0.03% Nasdaq 0.00%
Headlines
